HeXun Biosciences Co (ROCO:6986) OCF Yield %: 6.69 (As of Jul. 12, 2026)


ROCO:6986 HeXun Biosciences Co Ltd ROCO:6986
23 GF Score
Price NT$47.00
! 1 Warning Sign
View Full Analysis

What is HeXun Biosciences Co OCF Yield %?

HeXun Biosciences Co ROCO:6986 23 OCF Yield % is 6.69 as of Jul. 12, 2026. GuruFocus rates ROCO:6986 with a GF Score™ of 23/100. The stock has 1 warning sign investors should review. Among 1,410 Biotechnology companies, HeXun Biosciences Co ranks better than 93.19% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, HeXun Biosciences Co's Trailing 12-Month Cash Flow from Operations is NT$0.0 Mil, and Market Cap is NT$2,450.3 Mil. Therefore, HeXun Biosciences Co's OCF Yield % for today is 6.69%.

The historical rank and industry rank for HeXun Biosciences Co's OCF Yield % or its related term are showing as below:

ROCO:6986' s OCF Yield % Range Over the Past 10 Years
Min: 6.69   Med: 0   Max: 6.69
Current: 6.69


During the past 6 years, the highest OCF Yield % of HeXun Biosciences Co was 6.69%. The lowest was 6.69%. And the median was %.

ROCO:6986's OCF Yield % is ranked better than
93.19% of 1410 companies
in the Biotechnology industry
Industry Median: -8.26 vs ROCO:6986: 6.69

HeXun Biosciences Co's OCF Margin % for the quarter that ended in Dec. 2025 was %.


HeXun Biosciences Co OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


HeXun Biosciences Co OCF Yield % Related Terms


HeXun Biosciences Co OCF Yield % Historical Data

* Premium members only.

The historical data trend for HeXun Biosciences Co's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeXun Biosciences Co OCF Yield % Chart

HeXun Biosciences Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial 0.00 0.00 1.45 3.95 4.96

HeXun Biosciences Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ROCO:6986 vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, HeXun Biosciences Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeXun Biosciences Co OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HeXun Biosciences Co's OCF Yield % distribution charts can be found below:

* The bar in red indicates where HeXun Biosciences Co's OCF Yield % falls into.


ROCO:6986
23GF Score
HeXun Biosciences Co Ltd ROCO:6986
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeXun Biosciences Co OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

HeXun Biosciences Co's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=163.894 / 3305.2956
=4.96%

HeXun Biosciences Co's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=0 * 4 / 3305.2956
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 6.69 mean?
HeXun Biosciences Co (ROCO:6986) has a OCF Yield % of 6.69 as of Jul. 12, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on HeXun Biosciences Co and its competitors. Over the past decade, HeXun Biosciences Co's OCF Yield % has ranged from 6.69 to 6.69. According to the industry distribution chart, HeXun Biosciences Co ranks #96 out of 1410 companies in the Biotechnology industry, placing it in the top 6.8%.
Is HeXun Biosciences Co's OCF Yield % too high?
HeXun Biosciences Co's current OCF Yield % is 6.69. Over the past 10 years, this metric has ranged from a low of 6.69 to a high of 6.69. Based on the distribution chart, HeXun Biosciences Co ranks #96 out of 1410 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, HeXun Biosciences Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does HeXun Biosciences Co's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, HeXun Biosciences Co ranks #96 out of 1410 companies for OCF Yield %. This places HeXun Biosciences Co in the top 7% of its industry — outperforming the majority of peers. Historically, HeXun Biosciences Co's own OCF Yield % has ranged from 6.69 to 6.69 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on HeXun Biosciences Co and its competitors. HeXun Biosciences Co's current OCF Yield % is 6.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeXun Biosciences Co stock overvalued right now?
HeXun Biosciences Co (ROCO:6986) has a current OCF Yield % of 6.69. The current OCF Yield % is 6.69. HeXun Biosciences Co's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For HeXun Biosciences Co (ROCO:6986), the current OCF Yield % is 6.69 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeXun Biosciences Co Business Description

Address Chunri Road, 6 F., No. 1490, Taoyuan District, Taoyuan, TWN
HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.
23GF Score

Get the complete analysis for ROCO:6986

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$47.00
Price